chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: COVID19
Symptoms: Body temperature, Chills, Headache, Myalgia, Pyrexia
Clinical narrative: High fever 101; Headache; Sore muscles; Chills; Redness at vaccine site and belowthe shot; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (High fever 101), HEADACHE (Headache), MYALGIA (Sore muscles), CHILLS (Chills) and VACCINATION SITE ERYTHEMA (Redness at vaccine site and belowthe shot) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (High fever 101), HEADACHE (Headache), MYALGIA (Sore muscles), CHILLS (Chills) and VACCINATION SITE ERYTHEMA (Redness at vaccine site and belowthe shot). At the time of the report, PYREXIA (High fever 101), HEADACHE (Headache), MYALGIA (Sore muscles), CHILLS (Chills) and VACCINATION SITE ERYTHEMA (Redness at vaccine site and belowthe shot) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101 (High) High fever 101.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.   No treatment information for the events was provided.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site erythema
Clinical narrative: High fever 101; Headache; Sore muscles; Chills; Redness at vaccine site and belowthe shot; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (High fever 101), HEADACHE (Headache), MYALGIA (Sore muscles), CHILLS (Chills) and VACCINATION SITE ERYTHEMA (Redness at vaccine site and belowthe shot) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (High fever 101), HEADACHE (Headache), MYALGIA (Sore muscles), CHILLS (Chills) and VACCINATION SITE ERYTHEMA (Redness at vaccine site and belowthe shot). At the time of the report, PYREXIA (High fever 101), HEADACHE (Headache), MYALGIA (Sore muscles), CHILLS (Chills) and VACCINATION SITE ERYTHEMA (Redness at vaccine site and belowthe shot) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101 (High) High fever 101.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.   No treatment information for the events was provided.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Illness, Pyrexia, Vomiting
Clinical narrative: coughing; fever of 100.7 deg; Sickness; vomited; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Sickness), VOMITING (vomited), PYREXIA (fever of 100.7 deg) and COUGH (coughing) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported.). Concomitant products included HYDROCORTISONE (HUMERA) for an unknown indication.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, the patient experienced ILLNESS (Sickness) and VOMITING (vomited). On 02-Apr-2021, the patient experienced PYREXIA (fever of 100.7 deg). On 05-Apr-2021, the patient experienced COUGH (coughing). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, ILLNESS (Sickness), PYREXIA (fever of 100.7 deg) and COUGH (coughing) had not resolved and VOMITING (vomited) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Nausea, Photophobia, Pyrexia
Clinical narrative: Sensitivity to light; Nausea; Muscle Pain; Fever; This spontaneous case was reported by a consumer and describes the occurrence of PHOTOPHOBIA (Sensitivity to light), NAUSEA (Nausea), MYALGIA (Muscle Pain) and PYREXIA (Fever) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure abnormal. Concomitant products included PREGABALIN for Anesthetic complication neurological, DULOXETINE for Antidepressant therapy, PROPRANOLOL for Blood pressure.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, the patient experienced PHOTOPHOBIA (Sensitivity to light), NAUSEA (Nausea), MYALGIA (Muscle Pain) and PYREXIA (Fever). At the time of the report, PHOTOPHOBIA (Sensitivity to light), NAUSEA (Nausea), MYALGIA (Muscle Pain) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment product information was provided.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy, Vaccination site pain
Clinical narrative: Pregnant patient received the 1st shot of Moderna vaccine; soreness at injection site; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnant patient received the 1st shot of Moderna vaccine) and VACCINATION SITE PAIN (soreness at injection site) in a 32-year-old female patient (gravida 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 06-May-2021. On 17-Mar-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnant patient received the 1st shot of Moderna vaccine) and VACCINATION SITE PAIN (soreness at injection site). On 17-Mar-2021, MATERNAL EXPOSURE DURING PREGNANCY (Pregnant patient received the 1st shot of Moderna vaccine) had resolved. On 19-Mar-2021, VACCINATION SITE PAIN (soreness at injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided. Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). At the time of the report, PAIN IN EXTREMITY (Sore arm) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. The patient did not take any treatment medication.   Reporter did not allow further contact
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Injection site warmth, Pain, Pain in extremity, Swelling
Clinical narrative: achy; Swollen; ifts her arm it is very achy; warm to the touch; injection arm sore/hurt; sore arm for a day or two; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm for a day or two), PAIN (achy), SWELLING (Swollen), PAIN (ifts her arm it is very achy) and INJECTION SITE WARMTH (warm to the touch) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm for a day or two). On 02-Apr-2021, the patient experienced PAIN (achy), SWELLING (Swollen), PAIN (ifts her arm it is very achy), INJECTION SITE WARMTH (warm to the touch) and INJECTION SITE PAIN (injection arm sore/hurt). At the time of the report, PAIN IN EXTREMITY (sore arm for a day or two), PAIN (achy), SWELLING (Swollen), PAIN (ifts her arm it is very achy), INJECTION SITE WARMTH (warm to the touch) and INJECTION SITE PAIN (injection arm sore/hurt) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information provided
Age: 16.0
Sex: U
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Under 18 years old received first dose; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Under 18 years old received first dose) in a 16-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 19-Mar-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Under 18 years old received first dose). On 19-Mar-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Under 18 years old received first dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided.  Treatment information was not provided.  Upon in internal review on 18 May 2021, the age was corrected to 16 years      This case was linked to US-MODERNATX, INC.-MOD-2021-066855 (E2B Linked Report). This case was linked to MOD-2021-066198, MOD-2021-066206 (Patient Link).; Sender's Comments: This report refers to a case of Product administration error for mRNA-1273, lot# (not reported) with no associated AEs. US-MODERNATX, INC.-MOD-2021-066855:For 17 year old patient
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, Product temperature excursion issue
Clinical narrative: Expired product administered; Vaccine administered after temperature excursion; This spontaneous case was reported by a health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine administered after temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after temperature excursion) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination.   No Medical History information was reported.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine administered after temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after temperature excursion). On 02-Apr-2021, EXPIRED PRODUCT ADMINISTERED (Vaccine administered after temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after temperature excursion) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   No concomitant medication information was provided. No treatment medication information was provided
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Rash on her neck, chest, back, and pelvic areas; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash on her neck, chest, back, and pelvic areas) in a 28-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Mar-2021, the patient experienced RASH (Rash on her neck, chest, back, and pelvic areas). At the time of the report, RASH (Rash on her neck, chest, back, and pelvic areas) was resolving. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided. Concomitant medication was not provided.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Pain in extremity
Clinical narrative: sore arm; headache; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), HEADACHE (headache) and FATIGUE (fatigue) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm), HEADACHE (headache) and FATIGUE (fatigue). The patient was treated with ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for Pain relief, at a dose of 1 dosage form. On 24-Mar-2021, HEADACHE (headache) and FATIGUE (fatigue) had resolved. On 26-Mar-2021, PAIN IN EXTREMITY (sore arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling
Clinical narrative: both hands swelled up; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (both hands swelled up) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 28A21A) for COVID-19 vaccination.     Concomitant products included OMEPRAZOLE, PAROXETINE and CETIRIZINE HYDROCHLORIDE for an unknown indication.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2021, the patient experienced PERIPHERAL SWELLING (both hands swelled up). At the time of the report, PERIPHERAL SWELLING (both hands swelled up) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Pharmacist suggested taking children's liquid Benadryl.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during breast feeding
Clinical narrative: breastfeeding; This spontaneous case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING BREAST FEEDING (breastfeeding) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, the patient experienced MATERNAL EXPOSURE DURING BREAST FEEDING (breastfeeding). At the time of the report, MATERNAL EXPOSURE DURING BREAST FEEDING (breastfeeding) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Product temperature excursion issue
Clinical narrative: Vaccine administered after temperature excursionVaccine administered after temperature excursion/frozen vaccine 47 minutes -13.79 C/refrigerator 59 minutes 12 C; Vaccine administered after temperature excursion/frozen vaccine 47 minutes -13.79 C/refrigerator 59 minutes 12 C; This spontaneous case was reported by a health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine administered after temperature excursionVaccine administered after temperature excursion/frozen vaccine 47 minutes -13.79 C/refrigerator 59 minutes 12 C) and PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after temperature excursion/frozen vaccine 47 minutes -13.79 C/refrigerator 59 minutes 12 C) in a 22-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine administered after temperature excursionVaccine administered after temperature excursion/frozen vaccine 47 minutes -13.79 C/refrigerator 59 minutes 12 C) and PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after temperature excursion/frozen vaccine 47 minutes -13.79 C/refrigerator 59 minutes 12 C). On 02-Apr-2021, EXPIRED PRODUCT ADMINISTERED (Vaccine administered after temperature excursionVaccine administered after temperature excursion/frozen vaccine 47 minutes -13.79 C/refrigerator 59 minutes 12 C) and PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after temperature excursion/frozen vaccine 47 minutes -13.79 C/refrigerator 59 minutes 12 C) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.     Concomitant and treatment information not provided
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Acne, Pyrexia, Rash, Vaccination site erythema, Vaccination site swelling
Clinical narrative: Pimples in the rash; It was warm to the touch; Arm rash eventually grew bigger,rash was after the first shot; Left arm itched; Left arm was red; Left arm was feverish; a welt at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of ACNE (Pimples in the rash), VACCINATION SITE WARMTH (It was warm to the touch), RASH (Arm rash eventually grew bigger,rash was after the first shot), VACCINATION SITE URTICARIA (Left arm itched) and VACCINATION SITE SWELLING (a welt at the injection site) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hypertension, Latex allergy (latex allergy) and Drug allergy (sulfa drug allergy). Concomitant products included HYDROCHLOROTHIAZIDE, LISINOPRIL (LISINOPRIL/HCTZ) from 2000 to an unknown date for Blood pressure high, ASPIRIN [ACETYLSALICYLIC ACID], MULTIVITAMINS & MINERALS PLUS LUTEIN and VITAMIN D3 for an unknown indication.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced VACCINATION SITE SWELLING (a welt at the injection site). On 14-Mar-2021, the patient experienced VACCINATION SITE URTICARIA (Left arm itched), VACCINATION SITE ERYTHEMA (Left arm was red) and PYREXIA (Left arm was feverish). On an unknown date, the patient experienced ACNE (Pimples in the rash), VACCINATION SITE WARMTH (It was warm to the touch) and RASH (Arm rash eventually grew bigger,rash was after the first shot). On 16-Mar-2021, ACNE (Pimples in the rash), VACCINATION SITE WARMTH (It was warm to the touch), RASH (Arm rash eventually grew bigger,rash was after the first shot), VACCINATION SITE URTICARIA (Left arm itched), VACCINATION SITE SWELLING (a welt at the injection site), VACCINATION SITE ERYTHEMA (Left arm was red) and PYREXIA (Left arm was feverish) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information were not provided.   Most recent FOLLOW-UP information incorporated above includes: On 15-May-2021: Reporter detail, Rechallenge details ,Patient demographics and Event outcome updated. On 16-Jul-2021: Follow up received on 16-JUL-2021 and contains no new significant information
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site urticaria, Vaccination site warmth
Clinical narrative: Pimples in the rash; It was warm to the touch; Arm rash eventually grew bigger,rash was after the first shot; Left arm itched; Left arm was red; Left arm was feverish; a welt at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of ACNE (Pimples in the rash), VACCINATION SITE WARMTH (It was warm to the touch), RASH (Arm rash eventually grew bigger,rash was after the first shot), VACCINATION SITE URTICARIA (Left arm itched) and VACCINATION SITE SWELLING (a welt at the injection site) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hypertension, Latex allergy (latex allergy) and Drug allergy (sulfa drug allergy). Concomitant products included HYDROCHLOROTHIAZIDE, LISINOPRIL (LISINOPRIL/HCTZ) from 2000 to an unknown date for Blood pressure high, ASPIRIN [ACETYLSALICYLIC ACID], MULTIVITAMINS & MINERALS PLUS LUTEIN and VITAMIN D3 for an unknown indication.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced VACCINATION SITE SWELLING (a welt at the injection site). On 14-Mar-2021, the patient experienced VACCINATION SITE URTICARIA (Left arm itched), VACCINATION SITE ERYTHEMA (Left arm was red) and PYREXIA (Left arm was feverish). On an unknown date, the patient experienced ACNE (Pimples in the rash), VACCINATION SITE WARMTH (It was warm to the touch) and RASH (Arm rash eventually grew bigger,rash was after the first shot). On 16-Mar-2021, ACNE (Pimples in the rash), VACCINATION SITE WARMTH (It was warm to the touch), RASH (Arm rash eventually grew bigger,rash was after the first shot), VACCINATION SITE URTICARIA (Left arm itched), VACCINATION SITE SWELLING (a welt at the injection site), VACCINATION SITE ERYTHEMA (Left arm was red) and PYREXIA (Left arm was feverish) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information were not provided.   Most recent FOLLOW-UP information incorporated above includes: On 15-May-2021: Reporter detail, Rechallenge details ,Patient demographics and Event outcome updated. On 16-Jul-2021: Follow up received on 16-JUL-2021 and contains no new significant information
Sex: F
Vaccine: COVID19
Symptoms: Headache, Nausea, Pain, Pain in extremity
Clinical narrative: Feeling Achy; headache; nauseous to stomach; Arm hurts; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 02-Apr-2021 and was forwarded to Moderna on 02-Apr-2021.    Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a patient (subsequently medically confirmed) and describes the occurrence of PAIN (Feeling Achy), HEADACHE (headache), NAUSEA (nauseous to stomach) and PAIN IN EXTREMITY (Arm hurts) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage form. On 01-Apr-2021, the patient experienced PAIN (Feeling Achy), HEADACHE (headache), NAUSEA (nauseous to stomach) and PAIN IN EXTREMITY (Arm hurts). At the time of the report, PAIN (Feeling Achy), HEADACHE (headache), NAUSEA (nauseous to stomach) and PAIN IN EXTREMITY (Arm hurts) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Caller states next day after receiving the product,she felt crappy, achy, arm hurts, chills, nauseous to stomach and body was achy,she felt headachy and she took a couple of aspirin.
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Feeling abnormal
Clinical narrative: Lightheadedness that won't go away; If someone tells me something, it would take some moments for me to answer; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Lightheadedness that won't go away) and FEELING ABNORMAL (If someone tells me something, it would take some moments for me to answer) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Mar-2021, the patient experienced DIZZINESS (Lightheadedness that won't go away) and FEELING ABNORMAL (If someone tells me something, it would take some moments for me to answer). At the time of the report, DIZZINESS (Lightheadedness that won't go away) and FEELING ABNORMAL (If someone tells me something, it would take some moments for me to answer) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment details were reported.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Tenderness, Vaccination site erythema, Vaccination site swelling, Vaccination site warmth
Clinical narrative: kind of itchy; warm to the touch; tender and sore; arm is very red; swollen; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (kind of itchy), VACCINATION SITE WARMTH (warm to the touch), TENDERNESS (tender and sore), VACCINATION SITE ERYTHEMA (arm is very red) and VACCINATION SITE SWELLING (swollen) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016b21a) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRURITUS (kind of itchy), VACCINATION SITE WARMTH (warm to the touch), TENDERNESS (tender and sore), VACCINATION SITE ERYTHEMA (arm is very red) and VACCINATION SITE SWELLING (swollen). At the time of the report, PRURITUS (kind of itchy), VACCINATION SITE WARMTH (warm to the touch), TENDERNESS (tender and sore), VACCINATION SITE ERYTHEMA (arm is very red) and VACCINATION SITE SWELLING (swollen) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. Treatment information was not provided. Upon in internal review on 04-Aug-2021, the age was corrected to 56 years
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Discomfort, Inappropriate schedule of product administration, Vaccination site erythema, Vaccination site induration, Vaccination site pain
Clinical narrative: Feels uncomfortable like something's there; Really hard and really sore; Itching; Burning/ really sore; Red around incision area; Swollen arm; She also received second dose 23 days after first dose; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (She also received second dose 23 days after first dose), DISCOMFORT (Feels uncomfortable like something's there), VACCINATION SITE INDURATION (Really hard and really sore), VACCINATION SITE PRURITUS (Itching) and VACCINATION SITE PAIN (Burning/ really sore) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031B21A and 026A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 31-Mar-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (She also received second dose 23 days after first dose). On 01-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced DISCOMFORT (Feels uncomfortable like something's there), VACCINATION SITE INDURATION (Really hard and really sore), VACCINATION SITE PRURITUS (Itching), VACCINATION SITE PAIN (Burning/ really sore), VACCINATION SITE ERYTHEMA (Red around incision area) and VACCINATION SITE SWELLING (Swollen arm). On 31-Mar-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (She also received second dose 23 days after first dose) had resolved. At the time of the report, DISCOMFORT (Feels uncomfortable like something's there), VACCINATION SITE INDURATION (Really hard and really sore), VACCINATION SITE PRURITUS (Itching), VACCINATION SITE PAIN (Burning/ really sore), VACCINATION SITE ERYTHEMA (Red around incision area) and VACCINATION SITE SWELLING (Swollen arm) had not resolved.            Action taken with mRNA-1273 in response to the events was not Applicable. Concomitant medications were not reported.  No treatment information was specified.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site swelling
Clinical narrative: Feels uncomfortable like something's there; Really hard and really sore; Itching; Burning/ really sore; Red around incision area; Swollen arm; She also received second dose 23 days after first dose; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (She also received second dose 23 days after first dose), DISCOMFORT (Feels uncomfortable like something's there), VACCINATION SITE INDURATION (Really hard and really sore), VACCINATION SITE PRURITUS (Itching) and VACCINATION SITE PAIN (Burning/ really sore) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031B21A and 026A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 31-Mar-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (She also received second dose 23 days after first dose). On 01-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced DISCOMFORT (Feels uncomfortable like something's there), VACCINATION SITE INDURATION (Really hard and really sore), VACCINATION SITE PRURITUS (Itching), VACCINATION SITE PAIN (Burning/ really sore), VACCINATION SITE ERYTHEMA (Red around incision area) and VACCINATION SITE SWELLING (Swollen arm). On 31-Mar-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (She also received second dose 23 days after first dose) had resolved. At the time of the report, DISCOMFORT (Feels uncomfortable like something's there), VACCINATION SITE INDURATION (Really hard and really sore), VACCINATION SITE PRURITUS (Itching), VACCINATION SITE PAIN (Burning/ really sore), VACCINATION SITE ERYTHEMA (Red around incision area) and VACCINATION SITE SWELLING (Swollen arm) had not resolved.            Action taken with mRNA-1273 in response to the events was not Applicable. Concomitant medications were not reported.  No treatment information was specified.
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Missed 2nd dose window; This spontaneous case was reported by a health care professional and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Missed 2nd dose window) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Mar-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Missed 2nd dose window). On 19-Mar-2021, PRODUCT DOSE OMISSION ISSUE (Missed 2nd dose window) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not reported.  No treatment information was specified.
Sex: F
Vaccine: COVID19
Symptoms: Wrong technique in product usage process
Clinical narrative: vaccine administered after temperature excursion; This spontaneous case was reported by a health care professional and describes the occurrence of WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (vaccine administered after temperature excursion) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2021, the patient experienced WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (vaccine administered after temperature excursion). On 02-Apr-2021, WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (vaccine administered after temperature excursion) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error, Product temperature excursion issue
Clinical narrative: Vaccine administered after temperature excursion; Vaccine administered after temperature excursion; This spontaneous case was reported by a health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after temperature excursion) and PRODUCT STORAGE ERROR (Vaccine administered after temperature excursion) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2021, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after temperature excursion) and PRODUCT STORAGE ERROR (Vaccine administered after temperature excursion). On 02-Apr-2021, PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after temperature excursion) and PRODUCT STORAGE ERROR (Vaccine administered after temperature excursion) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported  No treatment drugs were reported   This case was linked to US-MODERNATX, INC.-MOD-2021-066757 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-066757:Crossed linked
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Rash pruritic
Clinical narrative: A itchy rash to trunk of body to legs/ Rash and itchiness to the trunk of body, legs and arms.; This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC (A itchy rash to trunk of body to legs/ Rash and itchiness to the trunk of body, legs and arms.) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032M20A and 010A21A) for COVID-19 vaccination.     Concurrent medical conditions included Colitis microscopic, Depression, Pain, Inflammation and Sleep difficult. Concomitant products included BUDESONIDE for Colitis microscopic, CELECOXIB (CELEXA [CELECOXIB]) for Depression, MAGNESIUM for Inflammation, LORATADINE (LORTAB [LORATADINE]) for Pain, ZOLPIDEM TARTRATE (AMBIEN) for Sleep difficult.   On 02-Mar-2021 at 3:45 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Mar-2021 at 3:45 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-Apr-2021 at 3:00 AM,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced RASH PRURITIC (A itchy rash to trunk of body to legs/ Rash and itchiness to the trunk of body, legs and arms.). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Rash pruritic, at an unspecified dose and frequency and HYDROCORTISONE for Rash pruritic, at an unspecified dose and frequency. On 07-Apr-2021 at 8:00 AM, RASH PRURITIC (A itchy rash to trunk of body to legs/ Rash and itchiness to the trunk of body, legs and arms.) had resolved.            Action taken with mRNA-1273 in response to the  event s were Not Applicable.   Most recent FOLLOW-UP information incorporated above includes: On 16-May-2021: Outcome of the event, second dose information, medical history, treatment medication and concomitant medications were updated.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site erythema, Vaccination site induration, Vaccination site pruritus
Clinical narrative: Itchy around the injection site; Hardness around the injection site; Redness around the injection site; Fever; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itchy around the injection site), VACCINATION SITE INDURATION (Hardness around the injection site), VACCINATION SITE ERYTHEMA (Redness around the injection site) and PYREXIA (Fever) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, the patient experienced VACCINATION SITE PRURITUS (Itchy around the injection site). 01-Apr-2021, the patient experienced VACCINATION SITE INDURATION (Hardness around the injection site), VACCINATION SITE ERYTHEMA (Redness around the injection site) and PYREXIA (Fever). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PRURITUS (Itchy around the injection site), VACCINATION SITE INDURATION (Hardness around the injection site), VACCINATION SITE ERYTHEMA (Redness around the injection site) and PYREXIA (Fever) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Bone pain, Fatigue, Feeling of body temperature change, Hypoaesthesia, Pain in extremity
Clinical narrative: Worsening of the bone pain in the entire right arm from shoulder bone to fingers; Hot and cold; Numbness all over body; Pain in the Right Arm; Felt very tired; Fever; This spontaneous case was reported by a consumer and describes the occurrence of BONE PAIN (Worsening of the bone pain in the entire right arm from shoulder bone to fingers), FEELING OF BODY TEMPERATURE CHANGE (Hot and cold), HYPOAESTHESIA (Numbness all over body), PAIN IN EXTREMITY (Pain in the Right Arm) and FATIGUE (Felt very tired) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced FEELING OF BODY TEMPERATURE CHANGE (Hot and cold), HYPOAESTHESIA (Numbness all over body), PAIN IN EXTREMITY (Pain in the Right Arm), FATIGUE (Felt very tired) and PYREXIA (Fever). On 19-Mar-2021, the patient experienced BONE PAIN (Worsening of the bone pain in the entire right arm from shoulder bone to fingers). The patient was treated with OXYCODONE for Pain in arm, at a dose of UNK dosage form; OXYCODONE for Pain in arm, at an unspecified dose and frequency; NAPROXEN SODIUM (ALEVE) for Pain in arm, at a dose of UNK dosage form and NAPROXEN SODIUM (ALEVE) for Pain in arm, at an unspecified dose and frequency. On 20-Mar-2021, FEELING OF BODY TEMPERATURE CHANGE (Hot and cold), HYPOAESTHESIA (Numbness all over body), FATIGUE (Felt very tired) and PYREXIA (Fever) had resolved. At the time of the report, BONE PAIN (Worsening of the bone pain in the entire right arm from shoulder bone to fingers) had not resolved and PAIN IN EXTREMITY (Pain in the Right Arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported.   Most recent FOLLOW-UP information incorporated above includes: On 16-Jul-2021: Email correspondence received it does not contain new information
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Worsening of the bone pain in the entire right arm from shoulder bone to fingers; Hot and cold; Numbness all over body; Pain in the Right Arm; Felt very tired; Fever; This spontaneous case was reported by a consumer and describes the occurrence of BONE PAIN (Worsening of the bone pain in the entire right arm from shoulder bone to fingers), FEELING OF BODY TEMPERATURE CHANGE (Hot and cold), HYPOAESTHESIA (Numbness all over body), PAIN IN EXTREMITY (Pain in the Right Arm) and FATIGUE (Felt very tired) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced FEELING OF BODY TEMPERATURE CHANGE (Hot and cold), HYPOAESTHESIA (Numbness all over body), PAIN IN EXTREMITY (Pain in the Right Arm), FATIGUE (Felt very tired) and PYREXIA (Fever). On 19-Mar-2021, the patient experienced BONE PAIN (Worsening of the bone pain in the entire right arm from shoulder bone to fingers). The patient was treated with OXYCODONE for Pain in arm, at a dose of UNK dosage form; OXYCODONE for Pain in arm, at an unspecified dose and frequency; NAPROXEN SODIUM (ALEVE) for Pain in arm, at a dose of UNK dosage form and NAPROXEN SODIUM (ALEVE) for Pain in arm, at an unspecified dose and frequency. On 20-Mar-2021, FEELING OF BODY TEMPERATURE CHANGE (Hot and cold), HYPOAESTHESIA (Numbness all over body), FATIGUE (Felt very tired) and PYREXIA (Fever) had resolved. At the time of the report, BONE PAIN (Worsening of the bone pain in the entire right arm from shoulder bone to fingers) had not resolved and PAIN IN EXTREMITY (Pain in the Right Arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported.   Most recent FOLLOW-UP information incorporated above includes: On 16-Jul-2021: Email correspondence received it does not contain new information
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Headache, Limb discomfort, Lymph node pain
Clinical narrative: Painful lymph node on left side of her neck; Swollen lymph node on left side of her neck; Headache; Cannot lift her arm; Almost diarrhea; Chills; Nausea; Fever; Body aches; Pain immediately spread all over her left arm to the elbow; This spontaneous case was reported by a pharmacist and describes the occurrence of LIMB DISCOMFORT (Cannot lift her arm), DIARRHOEA (Almost diarrhea), LYMPH NODE PAIN (Painful lymph node on left side of her neck), PAIN (Pain immediately spread all over her left arm to the elbow) and HEADACHE (Headache) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 03A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in July 2020.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, the patient experienced PAIN (Pain immediately spread all over her left arm to the elbow). On 01-Apr-2021, the patient experienced LIMB DISCOMFORT (Cannot lift her arm), DIARRHOEA (Almost diarrhea), HEADACHE (Headache), CHILLS (Chills), NAUSEA (Nausea), PYREXIA (Fever) and MYALGIA (Body aches). On 02-Apr-2021, the patient experienced LYMPH NODE PAIN (Painful lymph node on left side of her neck) and LYMPHADENOPATHY (Swollen lymph node on left side of her neck). At the time of the report, LIMB DISCOMFORT (Cannot lift her arm), DIARRHOEA (Almost diarrhea), LYMPH NODE PAIN (Painful lymph node on left side of her neck), PAIN (Pain immediately spread all over her left arm to the elbow), HEADACHE (Headache), CHILLS (Chills), NAUSEA (Nausea), PYREXIA (Fever), MYALGIA (Body aches) and LYMPHADENOPATHY (Swollen lymph node on left side of her neck) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   It was reported that patient was experiencing all the symptoms, just to a lesser degree at the time of this case report.  No relevant concomitant medications were reported.  No treatment information was provided.